Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses. Their findings can support the design of an inhibitor that can target aggressive cancers.
Comprehensive gene panel testing, one of the exciting new tools in cancer diagnostics, warrants greater scrutiny — as does a federal program aimed at speeding up the review process for proposed new medical technologies. Those are conclusions of Yale medical experts who studied both and published a report in the Journal of the National Cancer Institute on Sept.
Three Mile Island, the nuclear power plant in Pennsylvania that’s been shuttered since 2019, could come back to life to meet Microsoft’s energy needs. ...
Vice President Kamala Harris may visit the US-Mexico border on Friday as her campaign looks to close the gap with former President Donald Trump on immigration. ...
Nebraska state Sen. Mike McDonnell announced Monday that he opposes efforts to change how the state allocates its electoral votes before the upcoming 2024 election. ...
أحد الأسباب النادرة للانحدار الإدراكي الوراثي المعروف باسم الاضطراب المرتبط بالسائل الدماغي النخاعي (CSF1R-RD) حصل على اسمه من الطفرات في جين مستقبل عامل تحفيز المستعمرات 1، الذي اكتشفته مايو كلينك. ويحدث فقدان الذاكرة مع تقدم الحالة، في حين تشمل الأعراض المبكرة تغيرات في الشخصية والقلق والاكتئاب وفقدان القدرة على التثبيط. وعلى الرغم من أن الاختبارات الجينية أصبحت متاحة على نطاق أوسع، إلا إنه لا يوجد علاج لهذا الاضطراب.
The uninsured rate in Missouri has dropped significantly, according to a new analysis by the Center for Advancing Health Services, Policy & Economics Research at Washington University in St. Louis.
Un raro trastorno de deterioro cognitivo hereditario conocido como Trastorno Relacionado con CSF1R (CSF1R-RD, por sus siglas en inglés) recibe su nombre debido a mutaciones en el gen CSF1R, descubierto por Mayo Clinic. La pérdida de memoria ocurre a medida que avanza la afección, mientras que los primeros síntomas incluyen cambios de personalidad, ansiedad, depresión y pérdida de inhibición. Las pruebas genéticas se han vuelto más ampliamente disponibles, pero no existe cura para la enfermedad.
Um transtorno raro de declínio cognitivo hereditário conhecido como Transtorno Relacionado ao CSF1R (CSF1R-RD, sigla em inglês) recebe o seu nome devido a mutações no gene CSF1R, descoberto pela Mayo Clinic. A perda de memória ocorre à medida que a condição avança, enquanto os primeiros sintomas incluem alterações de personalidade, ansiedade, depressão e perda de inibição. Os testes genéticos tornaram-se mais amplamente disponíveis, mas não há cura para a doença.